SURFACE LOGIX INC. ANNOUNCES $42 MILLION PRIVATE FINANCING TO ADVANCE MULTIPLE CLINICAL PROGRAMS

Surface Logix today announced it has closed on $32 million of a $42 million committed private financing. Under the terms of the deal, Surface Logix expects to bring in the $10 million second tranche upon the completion of specific milestones. Participants in the financing included current Surface Logix investors, Venrock Associates, Arch Venture Partners, CW Group, HBM Partners, TIAA-CREF, Healthcare Focus Fund and Intel Capital. Also participating were new investors Unilever Technology Ventures and selected individual investors.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/463f88d262a5c74a9f2c87156b06cd7a.html)